Equities

MeiraGTx Holdings PLC

MeiraGTx Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)4.18
  • Today's Change-0.18 / -4.13%
  • Shares traded307.77k
  • 1 Year change-20.53%
  • Beta1.2790
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments130116138
Total Receivables, Net232935
Total Inventory------
Prepaid expenses5.638.138.10
Other current assets, total1.021.672.42
Total current assets160154183
Property, plant & equipment, net156154126
Goodwill, net------
Intangibles, net1.122.082.57
Long term investments6.776.336.66
Note receivable - long term------
Other long term assets1.921.401.40
Total assets327318320
LIABILITIES
Accounts payable161715
Accrued expenses474431
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total4.202222
Total current liabilities678268
Total long term debt72710
Total debt72710
Deferred income tax00.190.20
Minority interest------
Other liabilities, total494766
Total liabilities189200135
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital694582529
Retained earnings (accumulated deficit)(554)(470)(341)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.44)6.05(2.67)
Total equity138118185
Total liabilities & shareholders' equity327318320
Total common shares outstanding644845
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.